US Patent Issued to Jenius Pharma on Oct. 28 for "Treatments for diseases and disorders that involve oxidative stress" (California Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,549, issued on Oct. 28, was assigned to Jenius Pharma LLC (Henderson, Nev.).

"Treatments for diseases and disorders that involve oxidative stress" was invented by Hampar L Karageozian (San Juan Capistrano, Calif.), Vicken H Karageozian (San Juan Capistrano, Calif.) and John Y Park (Santa Ana, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Peptide compounds and their use in treating diseases and disorders that cause, are caused by, or are characterized by cellular oxidative stress."

The patent was filed on June 6, 2023, under Application No. 18/206,415.

*For further information, including images, charts and tables, please visit: http://patft...